These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 22701040)
21. IL-15 is expressed by dendritic cells in response to type I IFN, double-stranded RNA, or lipopolysaccharide and promotes dendritic cell activation. Mattei F; Schiavoni G; Belardelli F; Tough DF J Immunol; 2001 Aug; 167(3):1179-87. PubMed ID: 11466332 [TBL] [Abstract][Full Text] [Related]
22. IL-2 is required for the activation of memory CD8+ T cells via antigen cross-presentation. Blachère NE; Morris HK; Braun D; Saklani H; Di Santo JP; Darnell RB; Albert ML J Immunol; 2006 Jun; 176(12):7288-300. PubMed ID: 16751372 [TBL] [Abstract][Full Text] [Related]
23. [Inducing hepatocellular carcinoma-specific cytotoxic T lymphocyte response using formed by fusion of FastDCs and allogeneic human hepatocellular carcinoma cells]. Guan X; Leng XS; Peng JR; Wei YH; Wang H; Yuan L Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(47):3332-6. PubMed ID: 16409838 [TBL] [Abstract][Full Text] [Related]
24. Increased production of pro-inflammatory cytokines and enhanced T cell responses after activation of human dendritic cells with IL-1 and CD40 ligand. Wesa A; Galy A BMC Immunol; 2002 Oct; 3():14. PubMed ID: 12385649 [TBL] [Abstract][Full Text] [Related]
25. Interleukin 35: Inhibitory regulator in monocyte-derived dendritic cell maturation and activation. Chen X; Hao S; Zhao Z; Liu J; Shao Q; Wang F; Sun D; He Y; Gao W; Mao H Cytokine; 2018 Aug; 108():43-52. PubMed ID: 29571039 [TBL] [Abstract][Full Text] [Related]
26. Il-21 enhances NK cell activation and cytolytic activity and induces Th17 cell differentiation in inflammatory bowel disease. Liu Z; Yang L; Cui Y; Wang X; Guo C; Huang Z; Kan Q; Liu Z; Liu Y Inflamm Bowel Dis; 2009 Aug; 15(8):1133-44. PubMed ID: 19322899 [TBL] [Abstract][Full Text] [Related]
27. Lipopolysaccharide modulation of dendritic cells is insufficient to mature dendritic cells to generate CTLs from naive polyclonal CD8+ T cells in vitro, whereas CD40 ligation is essential. Kelleher M; Beverley PC J Immunol; 2001 Dec; 167(11):6247-55. PubMed ID: 11714787 [TBL] [Abstract][Full Text] [Related]
28. Antigen presentation by an immature myeloid dendritic cell line does not cause CTL deletion in vivo, but generates CD8+ central memory-like T cells that can be rescued for full effector function. Dumortier H; van Mierlo GJ; Egan D; van Ewijk W; Toes RE; Offringa R; Melief CJ J Immunol; 2005 Jul; 175(2):855-63. PubMed ID: 16002683 [TBL] [Abstract][Full Text] [Related]
29. Induction of antigen-specific CD8+ cytotoxic T cells by dendritic cells co-electroporated with a dsRNA analogue and tumor antigen mRNA. Michiels A; Breckpot K; Corthals J; Tuyaerts S; Bonehill A; Heirman C; Thielemans K; Aerts JL Gene Ther; 2006 Jul; 13(13):1027-36. PubMed ID: 16511519 [TBL] [Abstract][Full Text] [Related]
30. IFN-alpha skews monocyte differentiation into Toll-like receptor 7-expressing dendritic cells with potent functional activities. Mohty M; Vialle-Castellano A; Nunes JA; Isnardon D; Olive D; Gaugler B J Immunol; 2003 Oct; 171(7):3385-93. PubMed ID: 14500632 [TBL] [Abstract][Full Text] [Related]
31. Lung CD103+ dendritic cells efficiently transport influenza virus to the lymph node and load viral antigen onto MHC class I for presentation to CD8 T cells. Ho AW; Prabhu N; Betts RJ; Ge MQ; Dai X; Hutchinson PE; Lew FC; Wong KL; Hanson BJ; Macary PA; Kemeny DM J Immunol; 2011 Dec; 187(11):6011-21. PubMed ID: 22043017 [TBL] [Abstract][Full Text] [Related]
32. Direct effect of dsRNA mimetics on cancer cells induces endogenous IFN-β production capable of improving dendritic cell function. Gatti G; Nuñez NG; Nocera DA; Dejager L; Libert C; Giraudo C; Maccioni M Eur J Immunol; 2013 Jul; 43(7):1849-61. PubMed ID: 23636788 [TBL] [Abstract][Full Text] [Related]
33. Human anti-pig NK cell and CD8 Madelon N; Puga Yung GL; Seebach JD Xenotransplantation; 2016 Nov; 23(6):479-489. PubMed ID: 27862343 [TBL] [Abstract][Full Text] [Related]
34. Preferential production of the IL-12(p40)/IL-23(p19) heterodimer by dendritic cells from human newborns. Vanden Eijnden S; Goriely S; De Wit D; Goldman M; Willems F Eur J Immunol; 2006 Jan; 36(1):21-6. PubMed ID: 16342235 [TBL] [Abstract][Full Text] [Related]
35. Cytotoxic activity of human dendritic cells is differentially regulated by double-stranded RNA and CD40 ligand. Vidalain PO; Azocar O; Yagita H; Rabourdin-Combe C; Servet-Delprat C J Immunol; 2001 Oct; 167(7):3765-72. PubMed ID: 11564793 [TBL] [Abstract][Full Text] [Related]
36. Dendritic cells generated in the presence of granulocyte-macrophage colony-stimulating factor and IFN-alpha are potent inducers of HIV-specific CD8 T cells. Carbonneil C; Aouba A; Burgard M; Cardinaud S; Rouzioux C; Langlade-Demoyen P; Weiss L AIDS; 2003 Aug; 17(12):1731-40. PubMed ID: 12891059 [TBL] [Abstract][Full Text] [Related]
37. Inhibition of IL-10 and TGF-β receptors on dendritic cells enhances activation of effector T-cells to kill cholangiocarcinoma cells. Thepmalee C; Panya A; Junking M; Chieochansin T; Yenchitsomanus PT Hum Vaccin Immunother; 2018 Jun; 14(6):1423-1431. PubMed ID: 29420117 [TBL] [Abstract][Full Text] [Related]
38. Human CD1c+ dendritic cells secrete high levels of IL-12 and potently prime cytotoxic T-cell responses. Nizzoli G; Krietsch J; Weick A; Steinfelder S; Facciotti F; Gruarin P; Bianco A; Steckel B; Moro M; Crosti M; Romagnani C; Stölzel K; Torretta S; Pignataro L; Scheibenbogen C; Neddermann P; De Francesco R; Abrignani S; Geginat J Blood; 2013 Aug; 122(6):932-42. PubMed ID: 23794066 [TBL] [Abstract][Full Text] [Related]
39. Cytokine deprivation of naive CD8+ T cells promotes minimal cell cycling but maximal cytokine synthesis and autonomous proliferation subsequently: a mechanism of self-regulation. Sad S; Krishnan L J Immunol; 1999 Sep; 163(5):2443-51. PubMed ID: 10452979 [TBL] [Abstract][Full Text] [Related]
40. Activated human NK and CD8+ T cells express both TNF-related apoptosis-inducing ligand (TRAIL) and TRAIL receptors but are resistant to TRAIL-mediated cytotoxicity. Mirandola P; Ponti C; Gobbi G; Sponzilli I; Vaccarezza M; Cocco L; Zauli G; Secchiero P; Manzoli FA; Vitale M Blood; 2004 Oct; 104(8):2418-24. PubMed ID: 15205263 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]